ArticleJournal of medical case reports2026
Targeted management of adenomyosis: frozen embryo transfer outcomes with GnRH-agonist and letrozole therapy: a case series.
Article in Journal of medical case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundAdenomyosis negatively impacts fertility treatment outcomes by lowering clinical pregnancy rates, reducing live birth rates, and increasing miscarriage rates following in vitro fertilization. Hormonal suppression therapy has emerged as a preferred treatment for patients with adenomyosis, particularly before endometrial preparation for frozen-thawed embryo transfer; however, the combination therapy for individualized patients can improve the outcomes. Here we present three cases in wherein we applied a combined protocol using GnRH agonists and letrozole for endometrial preparation in patients with severe adenomyosis undergoing euploid frozen embryo transfer with a single embryo. CASE PRESENTATION: Three women with Arabian (Emirati) ethnicity aged 31-32 year old with moderate and severe adenomyosis and histories of recurrent in vitro fertilization failures and miscarriages underwent a combined protocol using GnRH agonists and letrozole and diagnostic hysteroscopy with saline instillation followed by hormonal replacement therapy for euploid frozen embryo transfer. Our three cases resulted in deliveries at 36, 38, and 40 weeks.
conclusionsAdenomyosis-related infertility remains a challenge. This case series supports the potential efficacy of hormonal suppression by combining GnRH agonists, aromatase inhibitors, and diagnostic hysteroscopy with saline irrigation prior to the endometrial preparation for euploid frozen embryo transfer in patients with adenomyosis. This protocol offers a promising alternative for cases unresponsive to standard treatments, although further research is warranted to refine guidelines on treatment duration and dosage.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.